Latanoprost Versus Fotil

Pharmaceutical Research Network36 enrolled

Overview

To compare the intraocular pressure effect and safety of latanoprost 0.005% given every evening versus PTFC given twice daily.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Open-Angle Glaucoma Ocular Hypertension

Interventions

latanoprost 0.005%DRUG

FotilDRUG

placeboDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * adults with primary open-angle or pigment dispersion glaucoma, or ocular hypertension * untreated intraocular pressure should be between 24-36 mm Hg inclusive * visual acuity should be 5/50 or better in both eyes Exclusion Criteria: * presence of exfoliation syndrome or exfoliation glaucoma * contraindications to study medications * any anticipated change in systemic hypotensive therapy

Locations (5)

Gabinety Okulistyczne

Bydgoszcz, Poland

Kierownik Kliniki Okulistycznej Akademii Medycznej

Poznan, Poland

Instytut Jaskry

Warsaw, Poland

Katdra Klinika Okulityki Akademii Medycznej w Warszawie

Warsaw, Poland

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.